Antiretroviral agents
Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy for Pediatric HIV Infection
11
Comprehensive In Vitro Analysis of Simian Retrovirus Type 4 Susceptibility to Antiretroviral Agents
8
DIFFERENTIAL INTERACTIONS OF ANTIRETROVIRAL AGENTS WITH LXR, ER AND GR NUCLEAR RECEPTORS POTENTIAL CONTRIBUTING FACTORS OF ADVERSE EVENTS
18
POPULATION PHARMACOKINETICS OF ANTIRETROVIRAL AGENTS: AN OVERVIEW
11
Antiretroviral Agents Effectively Block HIV Replication after Cell-to-Cell Transfer
8
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.
6
SAR and Pharmacophore Based Designing of Some Antimalarial and Antiretroviral Agents: An INTERNET Based Drug Design Approach Soumendranath Bhakat
17
A Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children With Human Immunodeficiency Virus Infection
7
Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy: Impact on Bone Mineral Density in HIV-Infected Children
10
Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection
9
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
288
Individualization of antiretroviral therapy
17
Antifungal agents: Polyene, azole, antimetabolite, other and future agents
8
LICENSING PROCEDURES FOR AUTOMOBILE CLUB AGENTS (MOTOR CLUB AGENTS)
5
The Evolution of Agents
140
Impact for Agents
8
TITLE AGENTS / ABSTRACTORS / ESCROW AGENTS PROFESSIONAL LIABILITY APPLICATION
8
Agents in Bioinformatics
9
Adminware for ISP Agents. Introduction. Adminware for ISP 1 Agents
9